Lenvatinib, Tislelizumab Combined With Gemcitabine and Cisplatin (GPLET) in the Treatment of Advanced Cholangiocarcinoma

Condition:   Advanced Cholangiocarcinoma Interventions:   Drug: Lenvatinib, tislelizumab, gemcitabine and cisplatin;   Drug: Gemcitabine and cisplatin Sponsors:   Second Affiliated Hospital, School of Medicine, Zhejiang University;   The First Affiliated Hospital of Zhengzhou University;   The Affiliated Tumor Hospital of Xinjiang Medical University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials